2.22
price down icon2.63%   -0.06
after-market アフターアワーズ: 2.20 -0.02 -0.90%
loading
前日終値:
$2.28
開ける:
$2.14
24時間の取引高:
801.06K
Relative Volume:
0.14
時価総額:
$10.60M
収益:
-
当期純損益:
$-11.66M
株価収益率:
-0.2722
EPS:
-8.156
ネットキャッシュフロー:
$-11.09M
1週間 パフォーマンス:
-5.13%
1か月 パフォーマンス:
+16.84%
6か月 パフォーマンス:
-33.73%
1年 パフォーマンス:
-57.96%
1日の値動き範囲:
Value
$2.085
$2.35
1週間の範囲:
Value
$1.93
$2.86
52週間の値動き範囲:
Value
$1.53
$10.35

Phio Pharmaceuticals Corp Stock (PHIO) Company Profile

Name
名前
Phio Pharmaceuticals Corp
Name
セクター
Healthcare (1174)
Name
電話
(508) 767-3861
Name
住所
11 APEX DRIVE, SUITE 300A, MARLBOROUGH, MA
Name
職員
9
Name
Twitter
@phio_pharma
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
PHIO's Discussions on Twitter

PHIO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PHIO
Phio Pharmaceuticals Corp
2.22 10.60M 0 -11.66M -11.09M -8.156
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
438.40 112.90B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
683.08 75.06B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
665.68 40.45B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
277.16 35.75B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
120.88 28.98B 3.30B -501.07M 1.03B -2.1146

Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2020-08-05 開始されました H.C. Wainwright Buy

Phio Pharmaceuticals Corp (PHIO) 最新ニュース

pulisher
Jan 23, 2025

Phio Pharmaceuticals (PHIO) Stock Price, News & Analysis - MarketBeat

Jan 23, 2025
pulisher
Jan 22, 2025

Phio Pharmaceuticals CEO to Present Breakthrough Cancer Treatment at Renmark Virtual Roadshow - StockTitan

Jan 22, 2025
pulisher
Jan 21, 2025

Phio Pharmaceuticals Announces Closing of $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile

Jan 21, 2025
pulisher
Jan 21, 2025

Phio Pharmaceuticals Secures $1.83M Direct Offering to Advance Cancer Treatment Pipeline - StockTitan

Jan 21, 2025
pulisher
Jan 17, 2025

We Asked Retail What's Next For Phio Pharma After Monday's Blistering Rally: Most See More Room To Run - MSN

Jan 17, 2025
pulisher
Jan 16, 2025

Phio Pharmaceuticals Raises $1.83M in Direct Offering with Warrant Coverage at $3.00/Share - StockTitan

Jan 16, 2025
pulisher
Jan 16, 2025

Stock market news: Phio Pharmaceuticals +50.19%, DatChat +46.01% among top gainers during mid day trading - Business Upturn

Jan 16, 2025
pulisher
Jan 15, 2025

Stock market today: Phio Pharmaceuticals -20.76%, Soligenix -20.15% among biggest losers in early trading - Business Upturn

Jan 15, 2025
pulisher
Jan 15, 2025

Phio Pharmaceuticals Raises $2.5M Through Direct Offering at $3.00 Per Share - StockTitan

Jan 15, 2025
pulisher
Jan 15, 2025

Phio Pharmaceuticals sharply lower on equity offering - MSN

Jan 15, 2025
pulisher
Jan 14, 2025

Stock market news: Phio Pharmaceuticals -50.61%, Salarius Pharmaceuticals -28.61% among biggest losers during mid day trading - Business Upturn

Jan 14, 2025
pulisher
Jan 14, 2025

Stock market news: Eterna Therapeutics posted gain of 100.87% while Phio Pharmaceuticals saw loss of 50.44% during mid day trading - Business Upturn

Jan 14, 2025
pulisher
Jan 14, 2025

What's Going On With Phio Pharmaceuticals Stock Today? - Benzinga

Jan 14, 2025
pulisher
Jan 14, 2025

Stock market today: Phio Pharmaceuticals -41.48%, Aehr Test Systems -26.86% among biggest losers in early trading - Business Upturn

Jan 14, 2025
pulisher
Jan 14, 2025

Stock market today: Eterna Therapeutics gain over 136.63% while Phio Pharmaceuticals plunged by 40.25% in early trading - Business Upturn

Jan 14, 2025
pulisher
Jan 14, 2025

Nasdaq Jumps 150 Points; US Producer Prices Increase 0.2% In December - Benzinga

Jan 14, 2025
pulisher
Jan 14, 2025

Phio Pharmaceuticals Announces $3.19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile

Jan 14, 2025
pulisher
Jan 14, 2025

Phio stock surged 330%: Phio reports 100% tumor clearance - Markets.com

Jan 14, 2025
pulisher
Jan 14, 2025

Stocks to Watch in 2025: PHIO, LPTH, KAVL, Promising Innovations, Growth Opportunities, Etc. … more inside - newschannelnebraska.com

Jan 14, 2025
pulisher
Jan 14, 2025

Phio Pharma Stock Quadruples On Positive Data From Cancer Treatment Trial: Retail’s Elated - MSN

Jan 14, 2025
pulisher
Jan 13, 2025

Phio Pharmaceuticals skyrockets on skin cancer drug trial success - Mugglehead

Jan 13, 2025
pulisher
Jan 13, 2025

Stocks to Watch in 2025: PHIO, LPTH, KAVL, Promising Innovations, Growth Opportunities, Etc. ... more inside - openPR

Jan 13, 2025
pulisher
Jan 13, 2025

Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge - Benzinga

Jan 13, 2025
pulisher
Jan 13, 2025

Unlocking the Surge! Phio Pharmaceuticals Surprises Everyone with 300% Stock Surge - Elblog.pl

Jan 13, 2025
pulisher
Jan 13, 2025

Cancer-Focused Phio Pharmaceuticals Stock Gains 300% On MondayHere's Why - Benzinga

Jan 13, 2025
pulisher
Jan 13, 2025

Stock market news: Phio Pharmaceuticals +296.88%, Salarius Pharmaceuticals +153.67% among top gainers during mid day trading - Business Upturn

Jan 13, 2025
pulisher
Jan 13, 2025

Stock market news: Shallgo saw rise of 286.81% while Kairos Pharma was up by 176.47% during mid day trading - Business Upturn

Jan 13, 2025
pulisher
Jan 13, 2025

Stocks to Watch in 2025: PHIO, LPTH, KAVL and more - Markets.com

Jan 13, 2025
pulisher
Jan 13, 2025

Phio reports complete tumor clearance in two cancer patients By Investing.com - Investing.com South Africa

Jan 13, 2025
pulisher
Jan 13, 2025

US Stocks Mixed; Nasdaq Down Over 1% - Benzinga

Jan 13, 2025
pulisher
Jan 13, 2025

Stock market today: Phio Pharmaceuticals +289.93%, Sage Therapeutics +34.95% among the top gainers in early trading - Business Upturn

Jan 13, 2025
pulisher
Jan 13, 2025

Phio Pharma Shares Triple After Positive Trial Data for Cancer Treatment - MarketWatch

Jan 13, 2025
pulisher
Jan 13, 2025

Pre-Market Surge For Phio Pharmaceuticals Following Clinical Success - Stocks Telegraph

Jan 13, 2025
pulisher
Jan 13, 2025

PHIOPhio Pharmaceuticals Corp. Latest Stock News & Market Updates - StockTitan

Jan 13, 2025
pulisher
Jan 13, 2025

Phio reports complete tumor clearance in two cancer patients - Investing.com

Jan 13, 2025
pulisher
Jan 13, 2025

Phio Pharmaceuticals Announces Promising Results of Second Cohort from Its Ongoing Clinical Study of PH-762 - Newsfile

Jan 13, 2025
pulisher
Jan 13, 2025

Phio's Cancer Drug PH-762 Achieves Complete Tumor Clearance in Phase 1b Trial Patients - StockTitan

Jan 13, 2025
pulisher
Jan 13, 2025

Stock market today: Kairos Pharma saw rise of 130.20% and Salarius Pharmaceuticals was up by 180.52% in early trading - Business Upturn

Jan 13, 2025
pulisher
Jan 02, 2025

Phio reports potential hyperpigmentation treatment success - Investing.com

Jan 02, 2025
pulisher
Jan 02, 2025

Comfort Systems USA (FIX-N) QuotePress Release - The Globe and Mail

Jan 02, 2025
pulisher
Jan 02, 2025

Phio Pharmaceuticals Announces Publication in Clinical, Cosmetic and Investigational Dermatology - Newsfile

Jan 02, 2025
pulisher
Jan 02, 2025

Phio's RXI-231 Shows Promise in Groundbreaking Hyperpigmentation Treatment Study - StockTitan

Jan 02, 2025
pulisher
Jan 01, 2025

Why ACADIA Pharmaceuticals Inc. (ACAD) Is Skyrocketing - Yahoo Finance

Jan 01, 2025
pulisher
Dec 24, 2024

Phio Pharmaceuticals Corp. Announces Positive Safety Monitoring Committee Recommendation to continue to Third Dose Cohort in its Clinical Study of PH-762 - Marketscreener.com

Dec 24, 2024
pulisher
Dec 23, 2024

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile

Dec 23, 2024
pulisher
Dec 23, 2024

Phio Pharmaceuticals Announces $480K Direct Offering with Warrant Coverage to Boost Working Capital - StockTitan

Dec 23, 2024
pulisher
Dec 23, 2024

Phio Pharmaceuticals Rallies Following Key Trial and Funding Updates - Stocks Telegraph

Dec 23, 2024
pulisher
Dec 23, 2024

Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket - Benzinga

Dec 23, 2024
pulisher
Dec 19, 2024

As FedEx plans to spin off freight, can it cut costs even more? - Yahoo Finance

Dec 19, 2024
pulisher
Dec 19, 2024

Phio stock hits 52-week low at $2.13 amid market challenges - Investing.com

Dec 19, 2024
pulisher
Dec 19, 2024

Phio Pharmaceuticals Raises $1.15M Through Strategic Direct Offering and Warrant Placement - StockTitan

Dec 19, 2024

Phio Pharmaceuticals Corp (PHIO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
大文字化:     |  ボリューム (24 時間):